You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 127 No. 3, March 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Research Letters
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Ocular/ Adnexal Tumors
 •Ophthalmological Disorders, Other
 •Dermatology
 •Radiation Therapy
 •Melanoma
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Intraocular Involvement of Mycosis Fungoides

Monica Ralli, MD; Jonathan W. Goldman, MD; Eric Lee, MD; Lauren C. Pinter-Brown, MD; Ben J. Glasgow, MD; David Sarraf, MD

Arch Ophthalmol. 2009;127(3):343-345.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Mycosis fungoides (MF) is a malignant cutaneous T-cell lymphoma characterized by erythematous patches, plaques, and tumors. In later stages, noncutaneous involvement can ensue with visceral spread, lymphadenopathy, and Sézary syndrome.1 Intraocular extension is rare,2 and anterior chamber involvement has not been reported. We describe a case of bilateral hypopyon from intraocular MF involvement.

Report of a Case

A 68-year-old man with MF, stage T4N3M1B0 by TNMB classification,3 complicated by inguinal lymphadenopathy and epiglottal involvement had worsening vision over 2 weeks. He had previously been treated with UV light therapy enhanced with psoralen, gemcitabine hydrochloride, interferon, methotrexate sodium, and liposomal doxorubicin hydrochloride. Visual acuity was 20/25 OD and hand motions OS. His skin was diffusely hyperemic and edematous with several tumors (Figure 1A). Dense, bilateral, lobular-appearing hypopyon with admixed blood was present . . . [Full Text of this Article]


Comment

AUTHOR INFORMATION


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.